Grant Awarded for Manufacturing Biopharmeceuticals

by Mary Martialay on January 19, 2019

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has awarded Rensselaer a workforce development grant as part of a nearly $13 million round of recently announced funding, a value which includes cost sharing from participating organizations. The grant, in collaboration with Celegene and LumaCyte, LLC will, develop “characterization of cell therapy products by flow and laser force cytometry.” 

NIIMBL, a public-private partnership to advance innovation in biopharmaceutical manufacturing, is part of Manufacturing USA®, a network of 14 manufacturing institutes across the country that brings together industry, academia, and the public sector to propel promising research developments, accelerate new products to market, and train tomorrow’s workforce in order to secure America’s future.

NIIMBL is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce, and leverages additional support from industry, academic institutions, nonprofit organizations, and select state governments.